Charles Schwab Investment Management »

Aeglea Biotherapeutics shares owned by Charles Schwab Investment Management

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Charles Schwab Investment Management from 13F filings

Historical chart of Charles Schwab Investment Management investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Charles Schwab Investment Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $8.8M 380k 23.28
2024-09-30 $9.8M 333k 29.41
2024-06-30 $2.3M 98k 23.51
2024-03-31 $569k 15k 37.93